Trofinetide — Active Pharmaceutical Ingredient

Trofinetide is an active pharmaceutical ingredient found in 2 FDA-approved drug products. Forms: FOR SOLUTION, SOLUTION. Routes: ORAL.

This content is for informational purposes only. Always consult a healthcare professional.

Trofinetide (2 brand names, 2 dosage forms, 1 route)

Available dosage forms: FOR SOLUTION, SOLUTION.

Routes of administration: ORAL.

Brand Names

  • DAYBUE
  • DAYBUE STIX

Indications and Usage

DAYBUE and DAYBUE STIX are indicated for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older.

Contraindications

None.

Adverse Reactions

The following clinically significant adverse reactions are described elsewhere in labeling: Diarrhea [see Warnings and Precautions (5.1)] Weight Loss [see Warnings and Precautions (5.2)] Vomiting [see Warnings and Precautions (5.3)]

Mechanism of Action

The mechanism by which trofinetide exerts therapeutic effects in patients with Rett syndrome is unknown.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.